Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Teva Pharmaceutical Industries, FRN 19dec2011, USD
US88166BAA89

Download
Copy issue information to clipboard
Copy issue information to clipboard
✓
Copy

Floating rate

Issue
Issuer
  • M
    -
    ****
  • S&P
    -
    ****
  • F
    -
    ****
*in foreign currency
Status
Matured
Amount
500,000,000 USD
Placement
***
Early redemption
*** (-)
Country of risk
Israel
Current coupon
***%
Price
***%
Yield / Duration
-
Calculator What is a calculator?
Corporate Actions Issuer news
Calculator
What is a calculator?
Register
to order full access
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Files

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Bond is not traded; the issue is redeemed
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
from
to
ADD-IN
Cbonds add-in API
bond data api
More than 2,500 records have been found, please specify your request
* Data is not available within the selected subscription
Latest data on

Issue information

Profile
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
Volume
  • Amount
    500,000,000 USD
Nominal
  • Minimum Settlement Amount
    2,000 USD
  • Outstanding face value
    *** USD
  • Par amount, integral multiple
    *** USD
  • Nominal
    1,000 USD

Cash flow parameters

  • Reference rate
    3M LIBOR USD
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Delay days
    *** days
  • Maturity date
    ***
  • Early redemption date
    ***

Early redemption terms

***

Register
to order full access
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Placement

  • Placement method
    Open subscription
  • Order book
    *** (***) - *** (***)
  • Coupon (Yield) Guidance
    ***% - ***% (*** - ***%)
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** USD
  • Number of bids
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***

Conversion and exchange

  • Convertion date
    ***
  • Initial premium
    ***%
  • Convertible until
    ***
  • Lock-up
    *** days
  • Conversion terms
    ***

Additional information

***

Latest issues

Show all

News

23/09/2020 New bond issue: Teva Pharmaceutical Industries issued international bonds (XS2198213956) with a 6% coupon for EUR 1,000.0m maturing in 2025
04/09/2020 S&P cut Teva's rating to BB-
04/09/2020 S&P Global Ratings downgrades Foreign Currency LT credit rating of Teva Pharmaceutical Industries to "BB-"; outlook stable
04/09/2020 S&P Global Ratings downgrades Local Currency LT credit rating of Teva Pharmaceutical Industries to "BB-"; outlook stable
26/08/2020 Teva Pharmaceutical Industries is officially accused of the price-fixing actions
19/08/2020 Department of Justice accused Teva Pharmaceutical's US Business of Violating Anti-Kickback Law
09/04/2020 Moody's Investors Service affirms Teva Pharmaceutical Industries at "Ba2" (LT- foreign currency credit rating); outlook negative
05/03/2020 Fitch Ratings affirms Teva Pharmaceutical Industries at "BB-" (LT Int. Scale (foreign curr.) credit rating); outlook negative
21/11/2019 New bond issue: Teva Pharmaceutical Industries issued international bonds (XS2083962691) with a 6% coupon for EUR 1,000.0m maturing in 2025
21/11/2019 New bond issue: Teva Pharmaceutical Industries issued international bonds (USN8540WAC84) with a 7.125% coupon for USD 1,000.0m maturing in 2025
All organization news

Stocks

Identifiers

  • Registration
    ***
  • Date of program registration
    ***
  • ISIN
    ***
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • Common Code
    051989694
  • CFI
    DBFGGR
  • FIGI
    BBG0000X6K50
  • Ticker
    TEVA F 12/19/11
  • Type of security by CBR
    ***

Ratings



Bond classification

  • Registered
  • Coupon bonds
  • Floating rate
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Indexed
  • Supranational bond issues
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

***

IFRS/US GAAP reports

2020
I q eng
II q eng
III q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
IV q eng
2016
IV q eng
2015
IV q eng
2014
IV q eng
Show all Hide
Copyright (c) 2004-2021 CbondS